Researchers assessed long-term effectiveness and tolerability of brivaracetam in patients with focal epilepsy. According to this multicenter retrospective study, brivaracetam was effective and well-tolerated in a large population of patients with predominantly drug-resistant epilepsy. There were no unexpected adverse events (AEs) over 1 year. The most frequently reported AEs were somnolence, irritability and dizziness.
April 5, 2019
October 22, 2019
CURE Discovery: Understanding and Treating NMDA Receptor-Associated Epilepsy
Researchers are studying whether off-label treatment with certain FDA-approved drugs can improve seizure control for individuals who have a GRIN mutation and whose epilepsy is caused by over-activation of NMDA-R.